BAYER AG |
Market Closed -
Other stock markets
|
Pre-market 02:03:29 am | |||
| 26.24 EUR | -0.04% |
|
25.96 | -1.09% |
| Apr. 18 | Bayer’s Investigational Gene Therapy for Heart Failure Gets US FDA Fast Track Designation | MT |
| Apr. 18 | Bayer: fast-track procedure in cardiology in the USA | CF |
Presenter SpeechO. Maier (Executives)[Audio Gap]
And before we st...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
Pharmaceuticals
Calendar
2024-04-26
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
26.24
EUR
Average target price
37.05
EUR
Spread / Average Target
+41.19%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -21.97% | 27.49B | |
| +27.97% | 672B | |
| +23.58% | 550B | |
| -7.02% | 351B | |
| +14.85% | 317B | |
| +6.25% | 292B | |
| +2.96% | 211B | |
| -0.41% | 203B | |
| -10.02% | 194B | |
| -11.81% | 144B |
- Stock Market
- Equities
- BAYN Stock
- News Bayer AG
- Transcript : Bayer Aktiengesellschaft - Analyst/Investor Day
